Nimodipine is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Ascend Laboratories, Llc. The primary component is Nimodipine.
Product ID | 67877-297_5752301d-2cfb-46cd-a9cf-86a8d6db2e28 |
NDC | 67877-297 |
Product Type | Human Prescription Drug |
Proprietary Name | Nimodipine |
Generic Name | Nimodipine |
Dosage Form | Capsule, Liquid Filled |
Route of Administration | ORAL |
Marketing Start Date | 2015-01-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA090103 |
Labeler Name | Ascend Laboratories, LLC |
Substance Name | NIMODIPINE |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA090103 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-01-01 |
Marketing Category | ANDA |
Application Number | ANDA090103 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-01-01 |
Ingredient | Strength |
---|---|
NIMODIPINE | 30 mg/1 |
SPL SET ID: | 2f4813da-931d-448d-bbe1-f0b90724af22 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0904-6566 | Nimodipine | Nimodipine |
23155-108 | Nimodipine | Nimodipine |
23155-512 | nimodipine | nimodipine |
55154-4184 | Nimodipine | Nimodipine |
57664-135 | Nimodipine | Nimodipine |
62559-210 | Nimodipine | Nimodipine |
63739-797 | Nimodipine | Nimodipine |
67877-297 | Nimodipine | Nimodipine |
68084-912 | Nimodipine | Nimodipine |
69452-209 | Nimodipine | Nimodipine |
24338-200 | Nymalize | nimodipine |
24338-205 | Nymalize | nimodipine |
24338-230 | Nymalize | nimodipine |
24338-260 | Nymalize | nimodipine |